EFDA eRIS Portal Workflow for Medical Device Applications in Ethiopia

1. Key takeaways

Ethiopia has moved all medical device applications onto the electronic Regulatory Information System (eRIS), accessible at www.eris.efda.gov.et. The system is built from three business modules: i-License, which handles application and renewal of the institutional competency certificate; i-Register, which handles new marketing authorization applications, variations and re-registration; and i-Import, which handles import permits and port clearance. Together the three modules form one continuous information chain running from the institution, to the product, to the shipped goods — and port inspectors can verify permits online.

The practical meaning of this chain is that nothing in the Ethiopian device approval process can be filed offline or out of order. A company that arrives at i-Register without the certificate produced by i-License, or at the port without the permit generated by i-Import, has no fallback channel: the modules feed one another, and every downstream step inherits the output of the one before it. Project planning for Ethiopia should therefore be module-based from the very first day, with the account, the certificate, the authorization and the permit sequenced deliberately rather than pursued in parallel.

2. Legal basis

3. Expert insights

Insight 1: accounts are opened only through authorized activation; foreign manufacturers cannot self-register. Section 11 of the general guidelines states that the applicant must obtain a username and password from authorized staff of the registration department of the authority before submitting online. This means that account access is itself a regulatory act: a foreign manufacturer cannot bypass the local agent to open its own account. Whoever holds the account controls the submission channel, so the agency agreement should address account custody, filing rights and the handling of credentials explicitly, rather than leaving these questions to be improvised after registration begins.

Insight 2: the three modules have a strict sequential dependency. i-License produces the institutional competency certificate; that certificate is a requirement under item 9.2.3(h) of the agency agreement at the i-Register stage; i-Register produces the marketing authorization; and that authorization is the precondition for i-Import to generate an import permit. If any module in the chain breaks, the modules after it cannot advance. A delay in certificate renewal, for example, does not stay confined to i-License — it propagates into every new application, every variation and every shipment until the certificate is restored.

Insight 3: all documents are uploaded in PDF format at the designated positions. The general guidelines require that all required documents be attached in PDF format at the corresponding attachment positions. The i-Register module likewise organizes files by administrative, technical and clinical sections. Non-standard folder structure and file naming directly reduce the screening pass rate. Because reviewers locate evidence by navigating the sections, a misfiled document behaves like a missing document, and the correction cycle consumes the same time as an incomplete submission.

Insight 4: import permits are generated automatically but can be voided. The eRIS description states that i-Import automatically generates the approved import permit certificate; however, the head of registration and licensing customer service may void an approved import permit certificate when modification is needed. Companies must therefore verify every field of the permit — product, quantity, consignee, validity — immediately after issuance. An error discovered during customs clearance leaves the shipment stranded while a corrected permit is regenerated, which is the most expensive possible moment to find a mistake.

Insight 5: the port stage is already linked online. The applicant submits the port clearance application online, and port inspectors can verify the import permit certificate online and release the consignment online. At the same time, the import permit certificate can also be used to apply for foreign exchange from banks. One certificate therefore serves two functions: customs clearance and currency purchase. Any inconsistency between the permit and the commercial documents surfaces in both places at once, so the permit data should be reconciled against the invoice and the banking paperwork before either process is started.

4. Practical recommendations

1. Arrange account activation through the local agent: foreign entities have no self-service channel.
2. Advance in module order: CoC, then MA, then import permit — the sequence cannot be skipped.
3. Convert all documents to PDF and name them by system section: this raises the screening pass rate.
4. Verify the import permit immediately after issuance: avoid a voided permit at the clearance stage.
5. Keep every online submission receipt: it is the proof of timeline compliance.
6. Use the import permit in the foreign-exchange process: confirm the required fields with the bank in advance.

5. Verification checklist

• □ eRIS account and access obtained through the local agent
• □ Institutional competency certificate obtained or renewed in i-License
• □ Marketing authorization application submitted in i-Register with PDF attachments
• □ Import permit obtained in i-Import and its information verified
• □ Port clearance application submitted online and receipts retained
• □ Usability of the import permit for bank foreign-exchange applications confirmed

Regulatory information verified as of October 29, 2026. The eRIS module names, processing order and functions described in this article follow the current EFDA system description and Section 11 of the general guidelines; when the system is upgraded or modules are adjusted, the content must be re-verified.

• Ethiopia local resource: GRZAN supports manufacturers from the Chinese mainland and overseas in working with the Ethiopian Food and Drug Authority (EFDA) on marketing authorization (MA) applications, the institutional competency certificate (CoC) and import permit applications, including local agent scheme design and agency agreement review, SRA reliance route justification, UMDN coding and classification determination, technical dossier preparation, and vigilance and post-market surveillance system setup.
• Service capabilities: product attribute determination and risk classification (non-IVD Class I–IV / IVD Class A–D), marketing authorization applications and re-registration, low-risk notification eligibility determination, Essential Principles conformity justification, English-language labeling and instructions-for-use localization, vigilance reporting and field safety corrective action support.
• Contact: hito.lin@grzan.cn; website www.grzan.cn. For EFDA registration pathway and classification strategy support for the Ethiopian market, write to info@grzanglobal.com.